Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares (NQ:LSE)

4.190 +0.240 (+6.08%)
Streaming Delayed Price Updated: 10:16 AM EDT, Jun 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting
From AVACTA GROUP PLC
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Notice of Availability of AGM Materials
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Caledonia approves quarterly dividend
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Short delay to the publication of financial results for the year ended December 31, 2024
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Here are the top movers in Thursday's session. ↗
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
Unusual volume stocks in Thursday's session ↗
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill
News headline image
Top movers in Thursday's session ↗
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
News headline image
Which stocks are gapping on Thursday? ↗
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
News headline image
Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Intended Retirement of Independent Non-executive Directors and changes of composition of board committees
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
HUTCHMED Highlights Savolitinib SAVANNAH Phase II and Other Data at European Lung Cancer Congress 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
News headline image
Nasdaq Gains Over 1%; Williams-Sonoma Shares Plunge After Q4 Results ↗
 
Via Benzinga
News headline image
HUTCHMED Reports 2024 Full Year Results and Provides Business Updates
65% oncology products revenue growth drove profitable operation and supported new ATTC platform 
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Nexxen Expands U.S. Partnership with Tubi to U.K.
Strategic partnership enhances advertiser engagement and monetisation in the growing U.K. streaming market 
From Nexxen International Ltd.
Via GlobeNewswire
News headline image
HUTCHMED and Innovent Jointly Announce that the FRUSICA-2 Phase II/III Study of Fruquintinib and Sintilimab Combination Has Met its Primary Endpoint in Advanced Renal Cell Carcinoma in China
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Executive Appointments Strengthen Nexxen’s Data, Streaming and Omnichannel Expertise
Strategic leadership hires enhance the company’s U.S. regional and global growth as well as its commitment to clients 
From Nexxen International Ltd.
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Notice of Results and Investor Presentation
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference
From AVACTA GROUP PLC
Via GlobeNewswire
News headline image
Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts
Encouraging Progression Free Survival (PFS) data observed in patients with salivary gland cancers compared to conventional treatments 
From AVACTA GROUP PLC
Via GlobeNewswire
News headline image
HUTCHMED Announces that it has Completed Enrollment of a Phase II Registration Study of Fanregratinib (HMPL-453) for Intrahepatic Cholangiocarcinoma in China
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
HUTCHMED to Announce 2024 Final Results
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Appointment of New Chief Financial Officer
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Leishen Energy Holding Co., Ltd. Announces Fiscal Year 2024 Financial Results Highlighting Strong Operating Cash Flow and Stable Gross Margins
From Leishen Energy Holding Co., Ltd.
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Appointments of Stefan Buys and Lesley Goldwasser as Non-Executive Directors
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Metals & Mining Virtual Investor Conference Agenda Announced for February 12th and 13th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
From HOOKIPA Pharma Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.